534 related articles for article (PubMed ID: 22102072)
21. Colonization with cagA-positive Helicobacter pylori strains in intestinal metaplasia of the esophagus and the esophagogastric junction.
Ackermark P; Kuipers EJ; Wolf C; Breumelhof R; Seldenrijk CA; Timmer R; Segeren KC; Kusters JG; Smout AJ
Am J Gastroenterol; 2003 Aug; 98(8):1719-24. PubMed ID: 12907324
[TBL] [Abstract][Full Text] [Related]
22. Blinded comparison of esophageal capsule endoscopy versus conventional endoscopy for a diagnosis of Barrett's esophagus in patients with chronic gastroesophageal reflux.
Lin OS; Schembre DB; Mergener K; Spaulding W; Lomah N; Ayub K; Brandabur JJ; Bredfeldt J; Drennan F; Gluck M; Jiranek GC; McCormick SE; Patterson D; Kozarek RA
Gastrointest Endosc; 2007 Apr; 65(4):577-83. PubMed ID: 17324414
[TBL] [Abstract][Full Text] [Related]
23. Dysplasia in short-segment Barrett's esophagus: a prospective 3-year follow-up.
Sharma P; Morales TG; Bhattacharyya A; Garewal HS; Sampliner RE
Am J Gastroenterol; 1997 Nov; 92(11):2012-6. PubMed ID: 9362182
[TBL] [Abstract][Full Text] [Related]
24. Cytokeratin subsets for distinguishing Barrett's esophagus from intestinal metaplasia in the cardia using endoscopic biopsy specimens.
El-Zimaity HM; Graham DY
Am J Gastroenterol; 2001 May; 96(5):1378-82. PubMed ID: 11374671
[TBL] [Abstract][Full Text] [Related]
25. Prevalence and risk factors associated with specialized intestinal metaplasia at the esophagogastric junction.
Kamberoglou DK; Savva SC; Kalapothakos PN; Koukounas ND; Doulgeroglou VG; Patra EG; Tzias VD
Hepatogastroenterology; 2002; 49(46):995-8. PubMed ID: 12143262
[TBL] [Abstract][Full Text] [Related]
26. Does Cytokeratin7/20 immunoreactivity help to distinguish Barrett's esophagus from gastric intestinal metaplasia? Results of a prospective study of 75 patients.
Schilling D; Spiethoff A; Rosenbaum A; Hartmann D; Eickhoff A; Jakobs R; Weickert U; Rebe M; Bohrer MH; Riemann JF
Pathol Res Pract; 2005; 200(11-12):801-5. PubMed ID: 15792123
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin immunoreactivity patterns in short-segment Barrett's esophagus in Japanese patients.
Yagi K; Nakamura A; Sekine A
J Gastroenterol Hepatol; 2005 Jun; 20(6):929-34. PubMed ID: 15946143
[TBL] [Abstract][Full Text] [Related]
28. A randomized, prospective cross-over trial comparing methylene blue-directed biopsy and conventional random biopsy for detecting intestinal metaplasia and dysplasia in Barrett's esophagus.
Ragunath K; Krasner N; Raman VS; Haqqani MT; Cheung WY
Endoscopy; 2003 Dec; 35(12):998-1003. PubMed ID: 14648410
[TBL] [Abstract][Full Text] [Related]
29. Detection of Barrett's esophagus after endoscopic healing of erosive esophagitis.
Hanna S; Rastogi A; Weston AP; Totta F; Schmitz R; Mathur S; McGregor D; Cherian R; Sharma P
Am J Gastroenterol; 2006 Jul; 101(7):1416-20. PubMed ID: 16863541
[TBL] [Abstract][Full Text] [Related]
30. Evaluation of Barrett's esophagus with CK7, CK20, p53, Ki67, and COX2 expressions using chromoendoscopical examination.
Çoban Ş; Örmeci N; Savaş B; Ekiz F; Ensari A; Kuzu I; Palabıyıkoğlu M
Dis Esophagus; 2013; 26(2):189-96. PubMed ID: 22591041
[TBL] [Abstract][Full Text] [Related]
31. Esophageal manometry and ambulatory 24-hour pH monitoring in patients with short and long segment Barrett's esophagus.
Loughney T; Maydonovitch CL; Wong RK
Am J Gastroenterol; 1998 Jun; 93(6):916-9. PubMed ID: 9647018
[TBL] [Abstract][Full Text] [Related]
32. Cytokeratin immunoreactivity of intestinal metaplasia at normal oesophagogastric junction indicates its aetiology.
Couvelard A; Cauvin JM; Goldfain D; Rotenberg A; Robaszkiewicz M; Fléjou JF;
Gut; 2001 Dec; 49(6):761-6. PubMed ID: 11709508
[TBL] [Abstract][Full Text] [Related]
33. Comparative study of intestinal metaplasia and mucin staining at the cardia and esophagogastric junction in 225 symptomatic patients presenting for diagnostic open-access gastroscopy.
Byrne JP; Bhatnagar S; Hamid B; Armstrong GR; Attwood SE
Am J Gastroenterol; 1999 Jan; 94(1):98-103. PubMed ID: 9934738
[TBL] [Abstract][Full Text] [Related]
34. CDX2 protein expression compared to alcian blue staining in the evaluation of esophageal intestinal metaplasia.
Johnson DR; Abdelbaqui M; Tahmasbi M; Mayer Z; Lee HW; Malafa MP; Coppola D
World J Gastroenterol; 2015 Mar; 21(9):2770-6. PubMed ID: 25759548
[TBL] [Abstract][Full Text] [Related]
35. Prevalence of intestinal metaplasia in the distal esophagus in patients endoscopically suspected for short Barrett's esophagus.
Grassi A; Giannarelli D; Iacopini F; Paoluzi P; Iannetti A; Giovannelli L; Efrati C; Barberani F; Giovannone M; Tosoni M
J Exp Clin Cancer Res; 2006 Sep; 25(3):297-302. PubMed ID: 17167967
[TBL] [Abstract][Full Text] [Related]
36. Barrett's esophagus in children with cystic fibrosis: not a coincidental association.
Hassall E; Israel DM; Davidson AG; Wong LT
Am J Gastroenterol; 1993 Nov; 88(11):1934-8. PubMed ID: 8237944
[TBL] [Abstract][Full Text] [Related]
37. Barrett's esophagus: a discrepancy between macroscopic and histological diagnosis.
Endlicher E; Rümmele P; Beer S; Knüchel R; Rath H; Schlottmann K; Grossmann J; Woenckhaus U; Schölmerich J; Messmann H
Endoscopy; 2005 Nov; 37(11):1131-5. PubMed ID: 16281145
[TBL] [Abstract][Full Text] [Related]
38. [Barrett carcinoma--diagnosis, screening, surveillance, endoscopic treatment, prevention].
Peitz U; Malfertheiner P
Z Gastroenterol; 2007 Dec; 45(12):1264-72. PubMed ID: 18080229
[TBL] [Abstract][Full Text] [Related]
39. The prevalence and clinical characteristics of short segments of specialized intestinal metaplasia in the distal esophagus on routine endoscopy.
Johnston MH; Hammond AS; Laskin W; Jones DM
Am J Gastroenterol; 1996 Aug; 91(8):1507-11. PubMed ID: 8759651
[TBL] [Abstract][Full Text] [Related]
40. Intestinal metaplasia of the gastric cardia.
Morales TG; Sampliner RE; Bhattacharyya A
Am J Gastroenterol; 1997 Mar; 92(3):414-8. PubMed ID: 9068460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]